Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols
Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion ($11.6 ...
Grifols spikes as banks reportedly finalize offers for buyout debt deal
Grifols (GRFS) stock gains as banks aim to finalize an €11B debt package for Brookfield's (BAM) plan to take the healthcare ...
Banks to Pitch Roughly €11 Billion Buyout Debt Deal for Grifols
Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion ($11.6 ...
Business Insider13h
EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged
This includes revenues from technology disclosure and from development services for Grifols, S.A. Previously, an increase in the high single-digit percentage range had been expected. The return on ...
PharmiWeb13h
Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged
Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged14-Nov-2024 / 08:56 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No ...
WZDX1d
Toys for Tots taking donations of new toys
From their website: The mission of the U.S. Marine Corps Reserve Toys for Tots Program is to collect new, unwrapped toys ...
Business Insider2d
Grifols price target raised to EUR 10 from EUR 9 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Grifols (GRFS) to EUR 10 from EUR 9 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving ...
Taiwan News2d
Nucleic Acid Amplification Testing (NAAT) Market Analysis, Technological Innovations, Applications, and Forecast 2024-2032
Report Ocean has published a new report on the Nucleic Acid Amplification Testing Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...
Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management ...
Grifols holder Mason Capital against potential Brookfield deal
Mason Capital opposes Grifols sale to Brookfield Asset Management, raising concerns about the potential acquisition in the ...
Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors
Mason Capital Management LLC ("Mason"), a registered investment advisor to funds and accounts holding approximately 2.1% of ...
devdiscourse6d
From Pulse to Profits: Key Developments in Global Health
Africa seeks U.S. vaccine commitment. Grifols and Moderna report promising earnings. Disparities in food health assessed ...